Filing Flows › Arcturus Therapeutics Holdings (ARCT) › Collaboration Revenue revenue
Arcturus Therapeutics Holdings (ARCT) Collaboration Revenue revenue by quarter
Arcturus Therapeutics Holdings' Collaboration Revenue revenue was $16.9M in Q3 2026 (third quarter 2026), up 19-fold from Q2 2026. Over the last 7 quarters it ranged from $610K (Q1 2026) to $25.5M (Q1 2025).
| Quarter | Collaboration Revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.9M | 19× | +19% |
| Q2 2026 | $880K | +44% | -96% |
| Q1 2026 | $610K | -80% | -98% |
| Q4 2025 | $3.1M | -78% | — |
| Q3 2025 | $14.2M | -42% | — |
| Q2 2025 | $24.5M | -4% | — |
| Q1 2025 | $25.5M | — | — |
Q3 2026 at a glance
Arcturus Therapeutics Holdings, Q3 2026: revenue $18.3M (+7% year over year), operating margin -50.2%, net loss $7.4M, operating cash flow −$6.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arcturus Therapeutics Holdings' Collaboration Revenue revenue?
Arcturus Therapeutics Holdings' Collaboration Revenue revenue was $16.9M in Q3 2026 (third quarter 2026), up 19-fold from Q2 2026.
How has Arcturus Therapeutics Holdings' Collaboration Revenue revenue changed?
Over the last 7 quarters it ranged from $610K (Q1 2026) to $25.5M (Q1 2025).
Q3 2026 results → · How Arcturus Therapeutics Holdings makes money →